{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:47:30Z","timestamp":1792273650162,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":499,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DK62277"],"award-info":[{"award-number":["1R01DK62277"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DK100287"],"award-info":[{"award-number":["1R01DK100287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA204586"],"award-info":[{"award-number":["1R01CA204586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ajpath.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T18:50:44Z","timestamp":1529347844000},"page":"1895-1909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Laura","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9865-3074","authenticated-orcid":false,"given":"Danielle","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Preziosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirthadipa","family":"Pradhan-Sundd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9131-1423","authenticated-orcid":false,"given":"Sucha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minakshi","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarangarajan","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chikina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satdarshan P.","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2018.05.006_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/aje\/kwj104","article-title":"Maternal and infant birth characteristics and hepatoblastoma","volume":"163","author":"McLaughlin","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajpath.2018.05.006_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2018.05.006_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2018.05.006_bib4","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1097-0142(20001015)89:8<1845::AID-CNCR27>3.0.CO;2-D","article-title":"Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors","volume":"89","author":"Perilongo","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2018.05.006_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pbc.22088","article-title":"Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group","volume":"53","author":"Meyers","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajpath.2018.05.006_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2018.05.006_bib7","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1073\/pnas.0603824103","article-title":"Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages","volume":"103","author":"Dan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.05.006_bib8","first-page":"269","article-title":"Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene","volume":"59","author":"Koch","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2018.05.006_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/path.1662","article-title":"Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas","volume":"204","author":"Koch","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2018.05.006_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pbc.20698","article-title":"Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?","volume":"47","author":"Aretz","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajpath.2018.05.006_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2741\/e393","article-title":"Activation of Wnt and Myc signaling in hepatoblastoma","volume":"4","author":"Cairo","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.ajpath.2018.05.006_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1478-3231.2011.02646.x","article-title":"Deregulation of Hippo kinase signalling in human hepatic malignancies","volume":"32","author":"Li","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2018.05.006_bib13","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","article-title":"YAP1 increases organ size and expands undifferentiated progenitor cells","volume":"17","author":"Camargo","year":"2007","journal-title":"Curr Biol"},{"key":"10.1016\/j.ajpath.2018.05.006_bib14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2006.08.042","article-title":"Conditional deletion of beta-catenin reveals its role in liver growth and regeneration","volume":"131","author":"Tan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2018.05.006_bib15","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/jhep.2001.23786","article-title":"Changes in WNT\/beta-catenin pathway during regulated growth in rat liver regeneration","volume":"33","author":"Monga","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2018.05.006_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2018.05.006_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9619-3","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer","volume":"108","author":"Bauer","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2018.05.006_bib18","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.18632\/oncotarget.1738","article-title":"Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer","volume":"5","author":"Candido","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2018.05.006_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2011.11.002","article-title":"Lipocalin 2 in cancer: when good immunity goes bad","volume":"316","author":"Rodvold","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2018.05.006_bib20","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.5301\/jbm.5000245","article-title":"Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? a systematic review of current evidence","volume":"32","author":"Roli","year":"2017","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.ajpath.2018.05.006_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2018.05.006_bib22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/CCM.0b013e318169245a","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock","volume":"36","author":"Wheeler","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajpath.2018.05.006_bib23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00467-006-0055-0","article-title":"Kidney NGAL is a novel early marker of acute injury following transplantation","volume":"21","author":"Mishra","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ajpath.2018.05.006_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2008.07.008","article-title":"NGAL in acute kidney injury: from serendipity to utility","volume":"52","author":"Devarajan","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajpath.2018.05.006_bib25","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1073\/pnas.0810617106","article-title":"Lipocalin 2 promotes breast cancer progression","volume":"106","author":"Yang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.05.006_bib26","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1158\/1078-0432.CCR-04-2391","article-title":"The matrix metalloproteinase-9\/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients","volume":"11","author":"Fernandez","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2018.05.006_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3892\/br.2013.89","article-title":"Neutrophil gelatinase-associated lipocalin protein as a biomarker in the diagnosis of breast cancer: a meta-analysis","volume":"1","author":"Wang","year":"2013","journal-title":"Biomed Rep"},{"key":"10.1016\/j.ajpath.2018.05.006_bib28","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1158\/0008-5472.CAN-08-0540","article-title":"Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer","volume":"68","author":"Tong","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2018.05.006_bib29","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/s00268-013-2009-6","article-title":"Lipocalin-2 is associated with a good prognosis and reversing epithelial-to-mesenchymal transition in pancreatic cancer","volume":"37","author":"Xu","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.ajpath.2018.05.006_bib30","doi-asserted-by":"crossref","first-page":"14058","DOI":"10.1073\/pnas.0710846105","article-title":"The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells","volume":"105","author":"Iannetti","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.05.006_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2407-11-229","article-title":"ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-kappaB-dependent manner","volume":"11","author":"Mahadevan","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2018.05.006_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.11005\/jbm.2016.23.1.8","article-title":"Deficiency of lipocalin-2 promotes proliferation and differentiation of osteoclast precursors via regulation of c-Fms expression and nuclear factor-kappa B activation","volume":"23","author":"Kim","year":"2016","journal-title":"J Bone Metab"},{"key":"10.1016\/j.ajpath.2018.05.006_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00894-015-2897-5","article-title":"Iron depletion strategy for targeted cancer therapy: utilizing the dual roles of neutrophil gelatinase-associated lipocalin protein","volume":"22","author":"Tang","year":"2016","journal-title":"J Mol Model"},{"key":"10.1016\/j.ajpath.2018.05.006_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2013analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2018.05.006_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2105-8-48","article-title":"Improved precision and accuracy for microarrays using updated probe set definitions","volume":"8","author":"Sandberg","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ajpath.2018.05.006_bib36","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2018.05.006_bib37","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","article-title":"ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments","volume":"26","author":"Lachmann","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2018.05.006_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2018.05.006_bib39","series-title":"National Research Council: Guide for the Care and Use of Laboratory Animals: Eighth Edition","year":"2011"},{"key":"10.1016\/j.ajpath.2018.05.006_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3727\/105221617X695762","article-title":"Role and regulation of p65\/beta-catenin association during liver injury and regeneration: a \u201ccomplex\u201d relationship","volume":"17","author":"Nejak-Bowen","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.ajpath.2018.05.006_bib41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"Lopez-Terrada","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2018.05.006_bib42","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1210\/me.2014-1092","article-title":"Lipocalin 2 is a regulator of macrophage polarization and NF-kappaB\/STAT3 pathway activation","volume":"28","author":"Guo","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajpath.2018.05.006_bib43","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4238\/2014.February.21.11","article-title":"Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) in colorectal cancer: a meta-analysis","volume":"13","author":"Wang","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.ajpath.2018.05.006_bib44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.21614\/chirurgia.111.5.414","article-title":"The diagnostic and prognostic significance of serum neutrophil gelatinase-associated lipocalin levels in patients with colorectal cancer","volume":"111","author":"Ozemir","year":"2016","journal-title":"Chirurgia (Bucur)"},{"key":"10.1016\/j.ajpath.2018.05.006_bib45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fphys.2016.00430","article-title":"Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy","volume":"7","author":"Asimakopoulou","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajpath.2018.05.006_bib46","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ejcts\/ezv199","article-title":"Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis","volume":"49","author":"Zhou","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ajpath.2018.05.006_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","article-title":"Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/beta-catenin perspective","volume":"17","author":"Bell","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.ajpath.2018.05.006_bib48","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/liv.12634","article-title":"The role of lipocalin-2 in liver regeneration","volume":"35","author":"Kienzl-Wagner","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2018.05.006_bib49","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hep.27447","article-title":"Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6\/STAT3","volume":"61","author":"Xu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2018.05.006_bib50","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/cas.13389","article-title":"Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer","volume":"108","author":"Kim","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2018.05.006_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-016-0564-9","article-title":"Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-kappaB-dependent activation of snail and epithelial mesenchymal transition","volume":"15","author":"Feng","year":"2016","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2018.05.006_bib52","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.26467","article-title":"Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)\/Lcn2\/Twist1 pathway","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017312361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017312361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:05:23Z","timestamp":1762081523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944017312361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0002944017312361"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.05.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}